Delivery Order SPE2DB20D1109-SPE2DB25FP67V
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,979.46 to AmerisourceBergen Drug Corp for the supply of Sandostatin LAR Depot 20 mg kits. This firm fixed-price, non-competitive delivery order was issued on August 12, 2025, with an ultimate completion date of August 13, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. This award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency's Medical Supply Chain awarded a $10,639.28 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for Sandostatin LAR Depot 20 mg kits, with performance completion targeted for July 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $92,418.76 to AmerisourceBergen Drug Corp for the supply of Sandostatin LAR Depot 20 mg kits. This firm fixed-price, competitively awarded delivery order was issued on September 15, 2025, with an ultimate completion date of September 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $14,833.72 delivery order to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 30 mg kits under a firm fixed price contract. The award, made on June 26, 2025, represents a child delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This award involved no set-aside designation and was competitively awarded...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $15,958.92 for Sandostatin LAR Depot 20 mg kits on September 4, 2025, with an ultimate completion date of September 5, 2025. This is a firm fixed price contract with no set-aside designation, representing a competitively awarded delivery order under the company's existing indefinite delivery contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $7,965.76 to AmerisourceBergen Drug Corp for the supply of Sandostatin LAR Depot 30 mg kits. The contract, issued on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a $20,091.40 delivery order to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 30 mg kits, with an ultimate completion date of August 4, 2025. This firm fixed price contract, awarded on August 1, 2025, represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $7,965.76 to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 30 mg kits on May 27, 2025, with completion targeted for May 28, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $20,024.51 to AmerisourceBergen Drug Corp for the supply of Sandostatin LAR Depot 30 mg kits under a firm fixed price contract. The award, issued on August 18, 2025, represents a competitively awarded, non-set-aside procurement with an ultimate completion date of August 19, 2025. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $10,639.28 delivery order on September 17, 2025, for Sandostatin LAR Depot 20 mg kits, a specialty pharmaceutical product used in the treatment of acromegaly and neuroendocrine tumors. This competitively awarded, firm fixed-price contract represents an individual delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP67VDelivery Order
This delivery order, awarded on September 3, 2025, by the Defense Logistics Agency to AmerisourceBergen Drug Corp, represents a $7,910.14 firm fixed-price procurement for Sandostatin LAR Depot 10 mg kits. The contract, which carries no set-aside designation, is set to conclude by September 4, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive pharmaceutical supply vehicle that runs through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical supplier primarily to the Defense Logistics Agency and military healthcare systems. The parent IDC enables the company to supply an extensive range of pharmaceutical products and medical commodities to support military health programs globally, including specialty medications, brand-name and generic drugs, and related medical supplies across multiple therapeutic domains. This specific delivery order for Sandostatin LAR Depot—an injectable medication used primarily for treating acromegaly and other conditions—reflects the company's ongoing role in fulfilling federal pharmaceutical procurement requirements through competitive, firm fixed-price delivery orders.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.9k | 9/3/25 |